CCL20 and triple-negative breast carcinoma: CCL20 was highly expressed in several cancer types such as colorectal malignancies [32, 33], metastatic triple-negative breast cancer [34], non-small-cell-lung-cancer [35], hepatic malignancies [36] and pancreatic carcinoma [37].